Diabetes in old age, a review

Iranian Journal of Diabetes and Lipid Disorders

Volumn 8, Issue 1, 2009, Pages 113-128

  Abbaszadeh Ahranjani, S ^a   Tabatabaei Malazy, O ^a   Pajouhi, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Education; Elderly

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE; REPAGLINIDE;

AGING; ANEMIA; BLOATING; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COST OF ILLNESS; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIARRHEA; FAMILY; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOGLYCEMIA; IRAN; LABORATORY TEST; LIVER TOXICITY; MEDICAL DECISION MAKING; MENTAL HEALTH; MOUTH DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PREVALENCE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; TOOTH DISEASE; VISUAL IMPAIRMENT;

EID: 75749124723     PISSN: 17267544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74. Diabetes 1987; 36: 523-34.
2. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16:157-77.
3. World Health Organization. The world health report 1997: Conquering Suffering, enriching humanity. Geneva: World Health Organization: 1997.
4. Khatib OMN. Diabetes in the Eastern Mediterranean Region. In: Guidelines for the prevention, management and care of diabetes mellitus. WHO regional office for the Eastern Mediterranean; 2006. p. 9-12.
5. Larijani B, Abolhasani F, Mohajeri Tehrani MR, et al. Prevalence of diabetes mellitus in Iran in 2000. Iranian Journal of Diabetes and Lipid Disorders 2005; 4(3): 75-83.
6. Canadian Diabetes Association. Clinical Practice Guidelines Expert Committee. Diabetes in the Elderly 2003:S106-S109.
7. Khoshbin S, Eshrati B, Azizabadi Farahani A, et al. An investigation into the status of the country's aged population in 2002. Iran's Ministry of Health, Treatment, and Medical Education, Deputy Health Office, Family and Population Health Bureau. 2007: 5-10
8. Abolhasani F, Mohagerie Tehrani MR, Tabatabaei O, et al. Burden of diabetes mellitus and its complications in Iran in year 2000. Iranian Journal of Diabetes and Lipid Disorders 2005; 5(1): 35-48.
9. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2007; 30(Suppl 1): S4-S41.
10. Harris MI, Flegal KM, Cowie CC. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-24.
11. Tessier D, Meneilly G. Diabetes management in the elderly. In: Gerstein HC, Haynes RB. Evidence-based diabetes care.1st edition, Canada. BC Decker Inc; 2001. p. 370-9.
12. Choi KM, Lee J, Kim DR, et al. Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans. Diabet Med 2002; 19: 853-857.
13. McBean AM, Gilbertson DT, Li Sh, et al. Differences in diabetes prevalence, incidence and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes care 2004; 27: 2317-2324.
14. Nakano T, Ito H. Epidemiology of diabetes mellitus in old age in Japan. Diabetes Research and Clinical Practice 2007; 77: S76-S81.
15. Varas-Lorenzo C, Rueda de Castro AM, Maguire A, et al. Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population. Pharmacoepidemiology and drug safety 2006; 15: 317-326.
16. Sloan FA, Bethel A, Jr DR, et al. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 2008; 168(2): 192-199.
17. Azizi F, Emami H, Salehi P, et al. Cardiovascular risk factors in the elderly: Tehran Lipid and Glucose Study (TLGS). Iranian Journal of Endocrinology and Metabolism 2003; 17(5): 3-14.
18. Dorosty AR, Alavi Naeini AM .Correlation of elderly nutritional status with cardio-vascular disease and diabetes. Tehran University Medical Journal 2007; 65(3): 68-71.
19. Naghavi M, Jamshidi HR. Receiving Health Services in 2002 in the Islamic Republic of Iran, Deputy Health Office, Center for Health Promotion. 2005: 5-58.
20. The Iranian Statistics Center, Publication List, National Statistics Portal. Available at: http://www.sci.org.ir/portal/faces/public /sci/sci.mahsulatvakhadamat/sci.paygah /sci.fehrest (access: 6 October 2008).
21. Schieber G, Klingen N. Health Financing Reform in Iran: Principles and Possible Next Steps. Social Security Research Institute Health Economic Congress Tehran, Islamic Republic of Iran October 30-November 1, 1999.
22. Motta M, Bennati E, Capri M, et al. Diabetes mellitus in the extreme longevity. Experimental Gerontology 2008; 43: 102-105.
23. IDF Asian-Pacific type 2 Diabetes Policy Group, type 2 diabetes. Practical Targets and treatments. Sydney: Health Communications Australia 1999.
24. Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Diabetes Metabol 2005; 31: 5S27-5S34.
25. Chau D, Edelman SV. Clinical Management of Diabetes in the Elderly. Clinical Diabetes 2001; 19(4): 172-175.
26. The Italian Longitudinal Study on Aging (ILSA) Working Group. Prevalence of chronic diseases in older Italians: Comparing self-reported and clinical diagnoses. Int J Epidemiol 1997; 26: 995-1002.
27. Motta M, Bennati E, Ferlito L, et al. A review on the actual trends of insulin treatment in elderly with diabetes. Arch Gerontol Geriatr 2008; 47: 151-61.
28. California Healthcare Foundation/American Geriatrics Society Panel on improving care for elders with diabetes. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. JAGS 2003; 51: S265-S280.
29. Bourdel-Marchasson I, Helmer C, Fagot-Campagna A, et al. Disability and quality of life in elderly people with diabetes. Diabetes & Metabolism 2007; 33: S66-S74.
30. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 1993; 16: 1167-78.
31. Larijani B, Khoramshahi Bayan M, Khalili Gorgani m, et al. Association of depression and diabetes in the doctor Shariati diabetes clinic and Iranian Diabetes Association. Iranian Journal of Diabetes and Lipid Disorders 2004; 3(1): 77-82.
32. Maraldi C, Volpato S, Penninx BW, et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons. Arch Intern Med 2007; 167: 1137-1144.
33. Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004; 27: 421-8.
34. Gregg EW, Engelgau MM, Narayan V. Complications of diabetes in elderly people. BMJ 2002; 325: 916-7.
35. Mohsen Khoshniat Niko 'Farah Madarshahian 'Mohsen Hassanabadi' et al .Comparative study of cognitive status in elderly with and without type 2 diabetes. Iranian Journal of Diabetes and Lipid Disorders 2007; 7(1): 71-6.
36. Naslafkih A, Se stier F. Diabetes mellitus related morbidity, risk of hospitalization and disability. J lnsur Med 2003; 35: 102-13.
37. Chanudet X, Bonnevie L, Bauduceau B. Coronary heart disease and cardiovascular autonomic neuropathy in the elderly diabetic. Diabetes & Metabolism 2007; 33: S19-S31.
38. Muggeo M, Verlato G, Bonora E, et al. The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 1995, 38: 318-25.
39. Cacciatori V, Bonora E, Travia D, et al. Comparison of elderly diabetes and mature age diabetes: similarities and differences. Archives of Gerontology and Geriatrics 1991; 2(Suppl): S223-S226.
40. Bethel MA, Sloan FA, Belsky D, et al. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007; 167: 921-927.
41. Gharipour M, Baghei A, Boshtam M, et al. Prevalence of metabolic syndrome among the adults of central of areas of Iran(as part of "Isfahan Healthy Heart Study"). J of Birjand University of medical Sciences 2006; 3(13): 56-62.
42. Nichols GA, Hillier TA, Erbey JR, et al. Congestive heart failure in type 2 diabetes. Diabetes Care 2001; 24:1614-9.
43. Solang L, Malmberg K, Ryden L. Diabetes mellitus and congestive heart failure. Eur Heart J 1999; 20: 789-95.
44. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trail. Available at: http://www.nhlbi.nih.gov/health/prof/heart/other/accord. Updated June 6, 2008.
45. Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 2006; 113: 799- 805.
46. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian J Diabetes 2003; 27(Suppl 2): S1-S152.
47. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32(Suppl 1): S13-S61
48. Chelliah A, Burge MR. Hypoglycaemia in Elderly Patients with Diabetes Mellitus. Causes and Strategies for Prevention. Drugs Aging 2004; 21(8): 511-530.
49. nd Edition. UK. John Wiley & Sons Ltd; 2001. p. 133-152.
50. Larijani B, Afshari M, Darvishzadeh F, et al. Lower limb amputation in patients with diabetic foot ulcer: a 22 year review. MJIRC 2006; 8(3): 21-4.
51. Endocrine and Metabolism Research Center, Tehran University of Medical Sciences; Regional- National Diabetes Guideline/Diabetic foot. Editors: Seyed Masoud Arzaghi, Ozra Tabatabaei Malazy, Tehran, in press by publisher: Charity Foundation for Special Diseases, 2009. Available in Persian language at http://emrc.tums.ac.ir/df lasted update 5/9/2009.
52. Lawrence SM, Wraight PR, Campbell DA, et al. Assessment and management of inpatients with acute diabetes-related foot complications: room for improvement. Internal Medicine Journal 2004; 34: 229-233.
53. Thomson FJ, Masson EA. Can elderly diabetic patients co-operate with routine foot care? Age and aging 1992; 21: 333-7.
54. Pataky Z, Vischer U. Diabetic foot disease in the elderly. Diabetes & Metabolism 2007; 33: S56-S65.
55. Forouzandeh F, Aziz Ahari A, Abolhasani f, et al. E valuation of foot neurovascular status in diabetic patients referred to diabetes clinic of Dr. Shariati Hospital, 2003-2004. Iranian Journal of Diabetes and Lipid Disorders 2005; 4(4): 43-52.
56. Shojaiefard A, Khorgami Z, Larijani B. Independent risk factors for amputation in diabetic foot. Int J Diab Dev Ctries 2008; 28: 32-7.
57. Shojaiefard A, Khorgami Z, Larijani B. Septic diabetic foot is not necessarily an indication for amputation. J Foot Ankle Surg 2008; 47: 419-23.
58. Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol (Online access) 2005; 5:24.
59. Forouzandeh F, Aziz Ahari A, Abolhasani F, Larijani B. Comparison of different screening tests for detecting diabetic foot neuropathy. Acta Neurol Scand 2005; 112:409-13.
60. nd edition, Chichester UK, John Wiley & Sons; 2001. p.119-131
61. Whiteside MM, Wallhagen M I, Pettengill E. Sensory impairment in older adults: part 2: vision loss. AJN 2006; 106(11): 52-61.
62. Massin P, Kaloustian E. The elderly diabetic's eyes. Diabetes & Metabolism 2007; 33: S4-S9.
63. Endocrine and Metabolism Research Center, Tehran University of Medical Sciences; Diabetes Guideline. Editors: Seyed Masoud Arzaghi, Sasan Sharghi, Tehran, publisher: Charity Foundation for Special Disesases, 2008. Available in http://vcemrc.tums.ac.ir/ lasted updated 2009, available in Persian language.
64. Wong T Y, Loon S-C, Saw S-M. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 2006; 90:506-11.
65. Manaviat MR, Afkhami Ardekani M. A study of the rate of presence of retinopathy in diabetic type II patients referring to the Yazd Diabetic Center. J of Shahid Sadoughi University of Medical Sciences and Health Services 2003; 4(10): 41-6.
66. Cahill M, Halley A, Codd M, et al. Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years. Br J Ophthalmol 1997; 81: 218-222.
67. Kato S, Takemori M, Kitano S, et al. Retinopathy in older patients with diabetes mellitus. Diabetes Research and Clinical Practice 2002; 58: 187-192.
68. De Voogd S, Ikarm MK, Wolfs RCW, et al. Is Diabetes Mellitus a Risk Factor for Open-Angle Glaucoma? Ophthalmology 2006; 113: 1827-1831.
69. American Diabetes Association. Nephropathy in Diabetes. Diabetes Care 2004; 27 (Suppl 1): S79-S83.
70. nd edition, Chichester UK, John Wiley & Sons; 2001. p.41-9.
71. Mohammadzadeh F, Omidfar K, Heshmat R, et al. Comparison of three methods of urine sampling for screening of albuminuria in diabetic patients using immunoturbidometric assay. Iranian Journal of Diabetes and Lipid Disorders 2007; 6(3): 219-24.
72. Valizadeh m, Nasser Farahmand A, Mousavi Nasab N, et al. Determining the value of albumin to creatinine ratio in a single morning sample, compared to the 24-Hour urinary albumin excretion test, for determining microalbuminuria in diabetic patients. Iranian Journal of Diabetes and Lipid Disorders 2009; 8: 27-36.
73. Nakhjavani M, Azmoudeh Ardalan F, Mazouji A. Relative frequency of microalbuminuria in patients with type 2 diabetes attending the diabetes clinic at Imam Khomeini University Hospital (2001-2). Iranian Journal of Diabetes and Lipid Disorders 2002; 2(1): 153-8.
74. Soell M, Hassan M, Miliauskaite A, et al. The oral cavity of elderly patients in diabetes. Diabetes & Metabolism 2007; 33: S10-S18.
75. Rad M, Hashemipour MS, Karimi MR. The relationship between oral manifestations in diabetes and duration of disease and glycemic control. Iranian Journal of Diabetes and Lipid Disorders 2006; 6(2): 159-67.
76. Diabetes and sexual function. Available in http://diabetes.ygoy.com lasted update October 2007.
77. Tabatabaei Malazy O, Shariat M, Heshmat R, et al. Vulvovaginal Candidiasis and its influencing factors in diabetes clinic of Dr. Shariati Hospital 2002-2005. Iranian Journal of Diabetes and Lipid Disorders 2006; 5(4): 345-352.
78. nd edition, Chichester UK, John Wiley & Sons; 2001. p.89-102.
79. Mofid A, Zandieh S, seyed Alinaghi SA, et al. Prevalence of erectile dysfunction in Tehranian diabetic men. Iranian South Medical J 2007; 1(10): 46-53.
80. Cayea D, Boyd C, Durso SC. Individualizing therapy for older adults with diabetes mellitus. Drugs Aging 2007; 24(10): 851-863.
81. Niefeld MR, Braunstein JB, Wu AW, et al. Preventable hospitalization among elderly medicare beneficiaries with type 2 diabetes. Diabetes Care 2003; 26: 1344-1349.
82. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162 (20): 2269-76.
83. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006; 29 (3): 725-31.
84. Tessier DM , Lassmann-Vague VJR. Diabetes and education in the elderly. Diabetes & Metabolism 2007; 33: S75-S78.
85. Tabatabaei Malazy O, Heshmat R, Taheri E, et al. Comparison of a generic and a brand metformin product in type II diabetes: A double blind randomized clinical trial study. DARU 2007; 15(2): 113-7.
86. Song MK ,Rosenthal MJ, Naliboff BD. Effects of bovine prostate powder on zinc, glucose and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism 1998; 47: 39-43.
87. Paolisso G, D'Amore A, Galzerano D. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type 2 diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-4.
88. Paolisso G, Scheen A, Cozzolino D. Changes in glucose turnover parameters and improvement of glucose oxidation after 4 week magnesium administration in elderly noninsulin-dependent (type 2) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-4.
89. Paolisso G, D'Amore A, Balbi V. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 1994; 266: E261-8.
90. Ligtenberg PC, Hoekstra JBL, Bol E. Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients. Clin Sci 1997; 93: 127-35.
91. Agurs-Collins TD, Kumanyika SK, Ten Have TR. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care 1997; 20: 1503-11.
92. Petterson T, Lee P, Hollis S, et al. Wellbeing and treatment satisfaction in older people with diabetes. Diabetes Care 1998; 21: 930-5.
93. Esteghamati A, Hassabi M, halabchi F, et al. Exercise prescription in patients with diabetes type 2. Iranian Journal of Diabetes and Lipid Disorders 2008; 7 : 1-15.
94. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 2002; 25(Suppl 1): S64-68.
95. Wilson M, Moore M P, Lunt H. Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Res Clin Pract 2004; 66: 263-7
96. Gilden JL, Hendryx M, Casia C. The effectiveness of diabetes education programs for older patients and their spouses. J Am Geriatr Soc 1989; 37: 1023-30.
97. Kronsbein P, Jorgens V, Venhaus A. Evaluation of a structured treatment and teaching program on non-insulindependent diabetes. Lancet 1988; 2: 1407-11.
98. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Can Med Assoc J 1998; 159(Suppl8): S1-29.
99. Salas M, Bubolz T, Caro JJ. Impact of physical functioning of health status on hospitalizations, physician visits, and costs in diabetic patients. Arch Med Res 2000; 31: 223-7.
100. nd edition. UK. John Wiley & Sons, Ltd; 2001. p.199-214.